Download PDF
CC BY-NC-ND 4.0 · Indian J Med Paediatr Oncol 2016; 37(02): 119-121
DOI: 10.4103/0971-5851.180139
CASE REPORT

Breast relapse after metastatic alveolar rhabdomyosarcoma: Is it an incurable entity?

Silvia López Iniesta
Division of Pediatric Oncology, University General Hospital, Alicante, Spain
,
Maria Tasso Cereceda
Division of Pediatric Oncology, University General Hospital, Alicante, Spain
,
Chevorn Suzette Adams
Division of Pediatric Oncology, University General Hospital, Alicante, Spain
,
Carlos Esquembre Menor
Division of Pediatric Oncology, University General Hospital, Alicante, Spain
› Author Affiliations Financial support and sponsorship Nil.
› Further Information
  PDF Download Permissions and Reprints

Abstract

Metastatic breast disease is a very rare condition in children. Rhabdomyosarcoma (RMS) is the most common solid primary tumor in children, but only a few cases of breast metastases have been described. We present the case of a young female with a primary pelvic metastatic alveolar RMS, which metastasized to the breast twice and achieved prolonged complete remission with a multimodal approach.

Keywords

Breast metastases - radiotherapy - soft tissue sarcomas


Publication History

Article published online:
12 July 2021

© 2016. Indian Society of Medical and Paediatric Oncology. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial-License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/.)

Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India

 

  • References

  • 1 Howarth CB, Caces JN, Pratt CB. Breast metastases in children with rhabdomyosarcoma. Cancer 1980;46:2520-4.
  • 2 Hanna NN, O'Donnell K, Wolfe GR. Alveolar soft part sarcoma metastatic to the breast. J Surg Oncol 1996;61:159-62.
  • 3 Perlet C, Sittek H, Forstpointner R, Kessler M, Reiser M. Metastases to the breast from rhabdomyosarcoma: Appearances on MRI. Eur Radiol 1999;9:1113-6.
  • 4 Carli M, Colombatti R, Oberlin O, Bisogno G, Treuner J, Koscielniak E, et al. European intergroup studies (MMT4-89 and MMT4-91) on childhood metastatic rhabdomyosarcoma: Final results and analysis of prognostic factors. J Clin Oncol 2004;22:4787-94.
  • 5 Breneman JC, Lyden E, Pappo AS, Link MP, Anderson JR, Parham DM, et al. Prognostic factors and clinical outcomes in children and adolescents with metastatic rhabdomyosarcoma — A report from the intergroup rhabdomyosarcoma study IV. J Clin Oncol 2003;21:78-84.
  • 6 Oberlin O, Rey A, Lyden E, Bisogno G, Stevens MC, Meyer WH, et al. Prognostic factors in metastatic rhabdomyosarcoma: Results of a pooled analysis from United States and European cooperative groups. J Clin Oncol 2008;26:2384-9.
  • 7 Pappo AS, Anderson JR, Crist WM, Wharam MD, Breitfeld PP, Hawkins D, et al. Survival after relapse in children and adolescents with rhabdomyosarcoma: A report from the intergroup rhabdomyosarcoma study group. J Clin Oncol 1999;17:3487-93.
  • 8 Gosiengfiao Y, Reichek J, Walterhouse D. What is new in rhabdomyosarcoma management in children? Paediatr Drugs 2012;14:389-400.
  • 9 D'Angelo P, Carli M, Ferrari A, Manzitti C, Mura R, Miglionico L, et al. Breast metastases in children and adolescents with rhabdomyosarcoma: Experience of the Italian soft tissue sarcoma committee. Pediatr Blood Cancer 2010;55:1306-9.
  • 10 Soft Tissue Sarcoma Committee of the Children's Oncology Group, Lager JJ, Lyden ER, Anderson JR, Pappo AS, Meyer WH, et al. Pooled analysis of phase II window studies in children with contemporary high-risk metastatic rhabdomyosarcoma: A report from the soft tissue sarcoma committee of the children's oncology group. J Clin Oncol 2006;24:3415-22.